共 3 条
[1]
Leonurine hydrochloride inhibits osteoclastogenesis and prevents osteoporosis associated with estrogen deficiency by inhibiting the NF-κB and PI3K/Akt signaling pathways.[J].Feng-Lai Yuan;Rui-Sheng Xu;Dong-Lin Jiang;Xing-Long He;Qiang Su;Chen Jin;Xia Li.Bone.2015,
[2]
Siglec-15 is a potential therapeutic target for postmenopausal osteoporosis.[J].Yusuke Kameda;Masahiko Takahata;Shintaro Mikuni;Tomohiro Shimizu;Hiroki Hamano;Takashi Angata;Shigetsugu Hatakeyama;Masataka Kinjo;Norimasa Iwasaki.Bone.2015,

